MicroRNA-21 induces 5-fluorouracil resistance in human pancreatic cancer cells by regulatingPTENandPDCD4
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-21 induces 5-fluorouracil resistance in human pancreatic cancer cells by regulatingPTENandPDCD4
Authors
Keywords
-
Journal
Cancer Medicine
Volume 5, Issue 4, Pages 693-702
Publisher
Wiley
Online
2016-02-10
DOI
10.1002/cam4.626
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stromal MicroRNA-21 levels predict response to 5-fluorouracil in patients with pancreatic cancer
- (2014) Timothy R. Donahue et al. JOURNAL OF SURGICAL ONCOLOGY
- Downregulation of miR-21 Enhances Chemotherapeutic Effect of Taxol in Breast Carcinoma Cells
- (2014) Mei Mei et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNA-21: a therapeutic target for reversing drug resistance in cancer
- (2013) Liu Hong et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN
- (2013) Shou-mei Yang et al. TOXICOLOGY
- Role of p70S6K1-mediated Phosphorylation of eIF4B and PDCD4 Proteins in the Regulation of Protein Synthesis
- (2012) Michael D. Dennis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA manipulation in colorectal cancer cells: from laboratory to clinical application
- (2012) Muhammad Imran Aslam et al. Journal of Translational Medicine
- Tumor Suppressor PDCD4 Represses Internal Ribosome Entry Site-Mediated Translation of Antiapoptotic Proteins and Is Regulated by S6 Kinase 2
- (2012) U. Liwak et al. MOLECULAR AND CELLULAR BIOLOGY
- MicroRNA-21 Modulates Chemosensitivity of Breast Cancer Cells to Doxorubicin by Targeting PTEN
- (2011) Zhao-Xia Wang et al. ARCHIVES OF MEDICAL RESEARCH
- Up-regulation ofmiR-21Mediates Resistance to Trastuzumab Therapy for Breast Cancer
- (2011) Chang Gong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
- (2010) Elisa Giovannetti et al. CANCER RESEARCH
- Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF
- (2010) Shadan Ali et al. CANCER RESEARCH
- Have Tumor Suppressor PDCD4 and its Counteragent Oncogenic miR-21 Gone Rogue?
- (2010) M. R. Young et al. MOLECULAR INTERVENTIONS
- MicroRNA dysregulation in gastric cancer: a new player enters the game
- (2010) W K K Wu et al. ONCOGENE
- Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer
- (2010) Jin-Hyeok Hwang et al. PLoS One
- MicroRNAs in Cancer
- (2009) Ramiro Garzon et al. Annual Review of Medicine
- MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme
- (2009) Yiming Li et al. BRAIN RESEARCH
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pdcd4, a colon cancer prognostic that is regulated by a microRNA
- (2009) Heike Allgayer CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Hyaluronan-CD44 Interaction with Protein Kinase Cϵ Promotes Oncogenic Signaling by the Stem Cell Marker Nanog and the Production of MicroRNA-21, Leading to Down-regulation of the Tumor Suppressor Protein PDCD4, Anti-apoptosis, and Chemotherapy Resistance in Breast Tumor Cells
- (2009) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Disruption of the Pdcd4 tumor suppressor gene in chicken DT40 cells reveals its role in the DNA-damage response
- (2009) P Singh et al. ONCOGENE
- Antisense Inhibition of microRNA-21 or -221 Arrests Cell Cycle, Induces Apoptosis, and Sensitizes the Effects of Gemcitabine in Pancreatic Adenocarcinoma
- (2009) Jong-Kook Park et al. PANCREAS
- Role of microRNAs in drug-resistant ovarian cancer cells
- (2008) Antonio Sorrentino et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started